ما هو علاج الالتهاب الرئوي اليوزيني المزمن؟

References

DOI: 10.2147/TCRM.S157882

• The mainstay of treatment is based on oral corticosteroid (OCS) therapy, with a goal of inducing remission as well as reducing the possibility of relapse.
• Initial treatment is typically oral prednisone dosed at 0.5–0.6 mg/kg/day with the dose tapering off by one-half after confirmation of both clinical and radiologic resolution.
• A review of the current literature regarding treatment by Suzuki et al suggests that a starting dose of prednisolone around 30 mg would be adequate.
• Treatment periods are variable from a few months to 12 months depending on the clinical response.
• Response to OCS is usually dramatic and fairly rapid, with both clinical improvement and resolution of infiltrates on imaging.
• Of note, response typically occurs within a few days, and if rapid clinical improvement is not seen, alternative diagnoses should be reconsidered.